|
Volumn 45, Issue 1, 2009, Pages 8-11
|
Managing cancer-related anaemia in congruence with the EORTC guidelines is an independent predictor of haemoglobin outcome: Initial evidence from the RESPOND study
c
Matrix45
*
(United States)
|
Author keywords
Anaemia; Erythropoietin; Evidence based practice guidelines
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ERYTHROPOIETIN;
HEMOGLOBIN;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
ARTICLE;
CANCER PATIENT;
CONTROLLED STUDY;
EVIDENCE BASED MEDICINE;
HEMATOLOGIC MALIGNANCY;
HUMAN;
MAJOR CLINICAL STUDY;
PATIENT CARE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SCORING SYSTEM;
VALIDATION STUDY;
|
EID: 57749201142
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ejca.2008.09.036 Document Type: Article |
Times cited : (19)
|
References (6)
|